Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam versus placebo for pediatric migraine prophylaxis
IRCT2017021632603N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Levetiracetam with Placebo (2 arms). Primary endpoints: Headache frequency and Headache intensity. Started Jul 2017; status: completed.
02
Drugs
levetiracetam
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT2017021632603N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017021632603N1.